Praxis Precision Medicines (PRAX) Stock Forecast & Price Target

Compare

650 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

PRAX Analyst Ratings

Moderate Buy

8 Buy

1 Hold

1 Sell

Based on 10 analysts giving stock ratings to

Praxis

Precision Medicines

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

PRAX Stock 12 Month Forecast

Average Price Target

$106.33

▲(131.45% Upside)

Based on 10 Wall Street analysts offering 12 month price targets for Praxis Precision Medicines in the last 3 months. The average price target is $106.33 with a high forecast of $270.00 and a low forecast of $33.00. The average price target represents a 131.45% change from the last price of $45.94.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"32":"$32","271":"$271","91.75":"$91.8","151.5":"$151.5","211.25":"$211.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":270,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$270.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":106.33,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$106.33</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":33,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$33.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[32,91.75,151.5,211.25,271],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,54.09,70.69846153846154,87.30692307692308,103.91538461538461,120.52384615384615,137.13230769230768,153.74076923076922,170.34923076923076,186.9576923076923,203.56615384615384,220.17461538461538,236.78307692307692,253.39153846153843,{"y":270,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,54.09,58.10846153846154,62.12692307692308,66.14538461538461,70.16384615384615,74.18230769230769,78.20076923076923,82.21923076923076,86.2376923076923,90.25615384615384,94.27461538461537,98.29307692307691,102.31153846153846,{"y":106.33,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,54.09,52.46769230769231,50.84538461538462,49.223076923076924,47.60076923076923,45.97846153846154,44.356153846153845,42.73384615384616,41.11153846153846,39.48923076923077,37.86692307692307,36.244615384615386,34.62230769230769,{"y":33,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":56.95,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.15,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57.43,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.33,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":77.86,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.96,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.55,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.6,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.87,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.06,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.82,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.17,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.09,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$270.00

Average Price Target$106.33

Lowest Price Target$33.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$48

Hold

4.48%

Upside

Reiterated

08/07/25

Praxis Precision Medicines faces significant financial challenges, which heavily impact its overall stock score. Despite positive clinical trial results and recent FDA designations, the company's financial health remains a major concern. Technical indicators show mixed signals, and valuation metrics are unfavorable due to ongoing losses. The positive sentiment from the earnings call and corporate events provides some support, but the financial performance is the most significant factor driving the low score.

Joon LeeTruist Financial

Truist Financial

―

Buy

―

Reiterated

08/05/25

Praxis Precision Medicines (PRAX) Gets a Buy from Truist Financial

Douglas TsaoH.C. Wainwright

H.C. Wainwright

$105→$115

Buy

150.33%

Upside

Reiterated

08/05/25

Promising Potential of Praxis Precision Medicines: Buy Rating Affirmed by Douglas Tsao

Ami FadiaNeedham

Needham

$80

Buy

74.14%

Upside

Reiterated

08/05/25

Positive Phase 2 Results for Praxis Precision Medicines' Vormatrigine Drive Buy Rating

Rudy LiChardan Capital

Chardan Capital

$80

Buy

74.14%

Upside

Reiterated

08/05/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Praxis Precision Medicines (NASDAQ: PRAX) and Pfizer (NYSE: PFE)

Ritu BaralTD Cowen

TD Cowen

$61

Buy

32.78%

Upside

Reiterated

08/04/25

Praxis Precision Medicines (PRAX) Receives a Buy from TD CowenTD Cowen analyst Ritu Baral reiterated a Buy rating and $61.00 price target on Praxis Precision Medicines Inc. (NASDAQ: PRAX).

Yatin SunejaGuggenheim

Guggenheim

$120→$155

Buy

237.40%

Upside

Reiterated

08/04/25

Praxis Precision Medicines (PRAX) Receives a Buy from Guggenheim

Laura ChicoWedbush

Wedbush

$28→$33

Sell

-28.17%

Downside

Reiterated

08/04/25

Praxis Precision Medicines (PRAX) Gets a Sell from WedbushWedbush analyst Laura Chico raised the price target on Praxis Precision Medicines Inc. (NASDAQ: PRAX) to $33.00 (from $28.00) while maintaining a Underperform rating.

Yasmeen RahimiPiper Sandler

Piper Sandler

$270

Buy

487.72%

Upside

Reiterated

07/10/25

Piper Sandler Keeps Their Buy Rating on Praxis Precision Medicines (PRAX)

Jay OlsonOppenheimer

Oppenheimer

$97→$115

Buy

150.33%

Upside

Reiterated

07/08/25

Praxis Precision Medicines (PRAX) Receives a Buy from Oppenheimer

Joel BeattyRobert W. Baird

Robert W. Baird

$73→$76

Buy

65.43%

Upside

Reiterated

05/05/25

Praxis Precision price target raised to $76 from $73 at BairdPraxis Precision price target raised to $76 from $73 at Baird

David HoangDeutsche Bank

Deutsche Bank

$111→$65

Buy

41.49%

Upside

Reiterated

03/03/25

Praxis Precision price target lowered to $65 from $111 at Deutsche BankPraxis Precision price target lowered to $65 from $111 at Deutsche Bank

Kambiz YazdiJefferies

Jefferies

$305

Buy

563.91%

Upside

Reiterated

01/22/25

Jefferies reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)Jefferies analyst Kambiz Yazdi reiterated a Buy rating and $305.00 price target on Praxis Precision Medicines Inc. (NASDAQ: PRAX)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$48

Hold

4.48%

Upside

Reiterated

08/07/25

Joon LeeTruist Financial

Truist Financial

―

Buy

―

Reiterated

08/05/25

Praxis Precision Medicines (PRAX) Gets a Buy from Truist Financial

Douglas TsaoH.C. Wainwright

H.C. Wainwright

$105→$115

Buy

150.33%

Upside

Reiterated

08/05/25

Promising Potential of Praxis Precision Medicines: Buy Rating Affirmed by Douglas Tsao

Ami FadiaNeedham

Needham

$80

Buy

74.14%

Upside

Reiterated

08/05/25

Positive Phase 2 Results for Praxis Precision Medicines' Vormatrigine Drive Buy Rating

Rudy LiChardan Capital

Chardan Capital

$80

Buy

74.14%

Upside

Reiterated

08/05/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Praxis Precision Medicines (NASDAQ: PRAX) and Pfizer (NYSE: PFE)

Ritu BaralTD Cowen

TD Cowen

$61

Buy

32.78%

Upside

Reiterated

08/04/25

Praxis Precision Medicines (PRAX) Receives a Buy from TD CowenTD Cowen analyst Ritu Baral reiterated a Buy rating and $61.00 price target on Praxis Precision Medicines Inc. (NASDAQ: PRAX).

Yatin SunejaGuggenheim

Guggenheim

$120→$155

Buy

237.40%

Upside

Reiterated

08/04/25

Praxis Precision Medicines (PRAX) Receives a Buy from Guggenheim

Laura ChicoWedbush

Wedbush

$28→$33

Sell

-28.17%

Downside

Reiterated

08/04/25

Yasmeen RahimiPiper Sandler

Piper Sandler

$270

Buy

487.72%

Upside

Reiterated

07/10/25

Piper Sandler Keeps Their Buy Rating on Praxis Precision Medicines (PRAX)

Jay OlsonOppenheimer

Oppenheimer

$97→$115

Buy

150.33%

Upside

Reiterated

07/08/25

Praxis Precision Medicines (PRAX) Receives a Buy from Oppenheimer

Joel BeattyRobert W. Baird

Robert W. Baird

$73→$76

Buy

65.43%

Upside

Reiterated

05/05/25

Praxis Precision price target raised to $76 from $73 at BairdPraxis Precision price target raised to $76 from $73 at Baird

David HoangDeutsche Bank

Deutsche Bank

$111→$65

Buy

41.49%

Upside

Reiterated

03/03/25

Praxis Precision price target lowered to $65 from $111 at Deutsche BankPraxis Precision price target lowered to $65 from $111 at Deutsche Bank

Kambiz YazdiJefferies

Jefferies

$305

Buy

563.91%

Upside

Reiterated

01/22/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Praxis Precision Medicines

1 Month

xxx

Success Rate

9/13 ratings generated profit

Average Return

+9.38%

reiterated a xxx

rating 7 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 69.23% of your transactions generating a profit, with an average return of +9.38% per trade.

3 Months

xxx

Success Rate

13/20 ratings generated profit

Average Return

+17.26%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 65.00% of your transactions generating a profit, with an average return of +17.26% per trade.

1 Year

Douglas TsaoH.C. Wainwright

Success Rate

13/27 ratings generated profit

Average Return

+74.35%

reiterated a buy rating 6 days ago

Copying Douglas Tsao's trades and holding each position for 1 Year would result in 48.15% of your transactions generating a profit, with an average return of +74.35% per trade.

2 Years

xxx

Success Rate

18/27 ratings generated profit

Average Return

+59.73%

reiterated a xxx

rating 6 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +59.73% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PRAX Analyst Recommendation Trends

Rating

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, PRAX has received 15 Buy Ratings, 9 Hold Ratings, and 1 Sell Ratings. PRAX average Analyst price target in the past 3 months is 106.33.

Each month's total comprises the sum of three months' worth of ratings.

PRAX Financial Forecast

PRAX Earnings Forecast

Next quarter’s earnings estimate for PRAX is -$3.29 with a range of -$3.86 to -$2.44. The previous quarter’s EPS was -$3.31. PRAX beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.76% of the time in the same period. In the last calendar year PRAX has Preformed in-line its overall industry.

PRAX Sales Forecast

Next quarter’s sales forecast for PRAX is $92.00K with a range of $0.00 to $500.00K. The previous quarter’s sales results were $0.00. PRAX beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.63% of the time in the same period. In the last calendar year PRAX has Preformed in-line its overall industry.

PRAX Stock Forecast FAQ

What is PRAX’s average 12-month price target, according to analysts?

Based on analyst ratings, Praxis Precision Medicines’s 12-month average price target is 106.33.

What is PRAX’s upside potential, based on the analysts’ average price target?

Praxis Precision Medicines has 131.45% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is PRAX a Buy, Sell or Hold?

Praxis Precision Medicines has a consensus rating of Moderate Buy which is based on 8 buy ratings, 1 hold ratings and 1 sell ratings.

What is Praxis Precision Medicines’s price target?

The average price target for Praxis Precision Medicines is 106.33. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $270.00 ,the lowest forecast is $33.00. The average price target represents 131.45% Increase from the current price of $45.94.

What do analysts say about Praxis Precision Medicines?

Praxis Precision Medicines’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of PRAX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Praxis Precision Medicines (PRAX) Stock Forecast & Price Target

PRAX Analyst Ratings

PRAX Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Praxis Precision Medicines

PRAX Analyst Recommendation Trends

PRAX Financial Forecast

PRAX Earnings Forecast

PRAX Sales Forecast

PRAX Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts